Prutis, containing Nintedanib, is an antifibrotic medicine widely prescribed for Idiopathic Pulmonary Fibrosis (IPF), Interstitial Lung Disease (ILD), and Systemic Sclerosis-associated ILD (SSc-ILD). These conditions are characterized by progressive lung fibrosis, leading to breathing difficulties, reduced oxygen levels, and decreased quality of life. Uses and Benefits Nintedanib ... https://www.prutis.com/